MaCeen board of directors has decided during their last meeting to appoint Mr. Badr AbdulRahman Al Musaibeh as the CEO of MaCeen Capital.
Mr. Bader Al Hammad , Board Member, MaCeen Capital, commented “this comes in line with the strategic vision of the company which requires us to apply the highest standards of corporate governance and control to ensure continuous growth and expansion of the company; We at MaCeen Capital believe in the great potential of the young Saudis who are the ideal solution for creating a mature market with bright minds that can keep up with the local and international economic changes and developments .”
In addition, Mr. Bader Al Hammad confirmed his high confidence in Mr. Badr AbdulRahman Al Musaibeh to lead MaCeen Capital according to the expectations and aspirations of the owners and the board of directors to deliver unconventional financial services for clients and ensure the continuous growth of their investments.
And from his part, Mr. Badr AbdulRahman Al Musaibeh, expressed his extreme gratitude for the trust given to him by the board of directors, he also added that he looks forward to taking the company to the next level in various fields, and to create the MaCeen Capital investment environment that reflects the power of the investment industry in the market via modern insights that are in compliance with the global changes and providing safe economic environments for their clients.
Al Musaibeh Also confirmed that he will dedicate his long experience in the Saudi financial market, which he acquired during his previous managerial positions in several companies in the Kingdom of Saudi Arabia, to elevate MaCeen Capital and occupy a leading position.
Al Musaibeh also added: “We will work to achieve the vision upon which the company was founded, which is to create various financial solutions, in the areas of investment banking , in addition to private equity which constitute the base station of future investment in the kingdom.
Sunday, July 6- 2014 @ 13:11 UAE local time (GMT+4) Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of Mediaquest FZ LLC.